RHUMBLINE ADVISERS - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$206,000
+32.1%
22,417
+10.8%
0.00%
Q4 2016$156,000
-26.4%
20,238
+9.3%
0.00%
-100.0%
Q3 2016$212,000
+1.9%
18,520
+9.6%
0.00%0.0%
Q2 2016$208,000
+24.6%
16,895
+2.6%
0.00%0.0%
Q1 2016$167,000
-54.6%
16,470
+1.0%
0.00%0.0%
Q4 2015$368,000
+49.0%
16,305
+9.7%
0.00%0.0%
Q3 2015$247,000
-23.3%
14,870
+4.0%
0.00%0.0%
Q2 2015$322,000
+5.6%
14,295
+20.8%
0.00%0.0%
Q1 2015$305,000
+36.8%
11,830
+15.6%
0.00%0.0%
Q4 2014$223,000
-3.5%
10,230
+3.0%
0.00%0.0%
Q2 2014$231,0009,9300.00%
Other shareholders

There were no reported owners of ONCOMED PHARMACEUTICALS INC in Q1 2016.

NameSharesValueWeighting ↓
View complete list of ONCOMED PHARMACEUTICALS INC shareholders